drugset / Trial / NCT03206138
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a study to investigate the safety and efficacy of GX-188E administered IM plus local administration of GX-I7 or Imiquimod at cervix in subjects with cervical intraepithelial neoplasia (CIN) 3.
Timeline
- Start
- 2017-05-30
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GX-188E | Vaccine | 1 mg | Intramuscular |
| Subject | Imiquimod | Other / unclassified | 12.5 mg | Topical |
| Subject | NT-I7 | Protein / enzyme biologic | 3 mg | Other |